share_log

Guggenheim Initiates Coverage On Cidara Therapeutics With Buy Rating, Announces Price Target of $33

Guggenheim Initiates Coverage On Cidara Therapeutics With Buy Rating, Announces Price Target of $33

古根海姆开始对cidara therapeutics 进行买入评级,宣布目标股价为33美元
Benzinga ·  11/08 06:31  · 评级/大行评级

Guggenheim analyst Seamus Fernandez initiates coverage on Cidara Therapeutics (NASDAQ:CDTX) with a Buy rating and announces Price Target of $33.

古根海姆分析师Seamus Fernandez发起对cidara therapeutics(纳斯达克:CDTX)的覆盖,给予买入评级,并宣布目标股价为33美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发